Xcovery Vision

Xcovery has formed a wholly owned subsidiary, Xcovery Vision, to leverage its novel kinase inhibitors in the field of ophthalmology. Xcovery Vision is focused on developing novel treatments for eye disease and is currently evaluating X-82 (VEGFR/PDGFR) in age related macular degeneration (AMD). For more information on Xcovery Vision, please visit their website www.xcoveryvision.com

Wet AMD. Blood vessels and scar tissue grow underneath the macula.